EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effector-Memory γδ T Lymphocytes Predict CMV Disease After the Withdrawal of Prophylaxis in Kidney Transplant Recipients

Yoann Abadie, Jonathan Visentin, Elodie Wojciechowski, Manon Charrier, Julie Déchanet-Merville, Isabelle Garrigue, Patrick Blanco, Pierre Merville, Hannah Kaminski, Lionel Couzi

Transplant International · 2025

DOI: 10.3389/ti.2025.14339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant International, 2025. Verfasst von Yoann Abadie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France. Hauptthemen laut MEDLINE: Kidney Transplantation, Cytomegalovirus Infections, Receptors, Antigen, T-Cell, gamma-delta, Memory T Cells. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evaluation of CMV-specific cell-mediated immunity (CMI) has improved strategies to prevent post-transplant CMV disease. This study assessed the association between CMV disease and absolute count of TEMRA γδ T cells at the end of universal prophylaxis in kidney transplant recipients (KTR). We retrospectively analyzed 262 R⁺ and 82 D⁺/R⁻ KTRs who received antiviral prophylaxis and had TEMRA γδ T cells quantified at the end of prophylaxis. The primary endpoint was CMV disease within two years post-transplant. Post-prophylaxis CMV disease occurred in 43/344 (12.5%) patients. A threshold of 4.65/mm³ for TEMRA γδ T-cell count was identified by ROC analysis; higher counts were associated with reduced CMV disease incidence. While no significant association was found in the overall cohort, in R⁺ patients, a count >4.65/mm³ was associated with a 97.7% positive predictive value for protection against CMV disease. Multivariate analysis confirmed its independent association with disease-free survival [HR: 0.27 (95% CI: 0.09–0.85), p = 0.0252]. Measuring TEMRA γδ T-cell counts at the end of prophylaxis may serve as a useful, accessible immune marker to guide CMV prevention strategies in R⁺ kidney transplant recipients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationCytomegalovirus InfectionsReceptors, Antigen, T-Cell, gamma-deltaMemory T CellsHumansMaleFemaleMiddle AgedRetrospective StudiesAdultAntiviral AgentsAgedLymphocyte CountDisease-Free Survival

Stichwörter der Autor:innen

CMVimmunologyimmunomonitoringinfectionprophylaxis

Substanzen

Antiviral AgentsReceptors, Antigen, T-Cell, gamma-delta

Autor:innen und Institutionen

  • Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France.
  • Centre National de la Recherche Scientifique - Unité Mixte de recherche (CNRS-UMR) 5164 ImmunoConcEpT, Bordeaux University, Bordeaux, France.
  • Laboratory of Immunology and Immunogenetics, Bordeaux University Hospital, Bordeaux, France.
  • Laboratory of Virology, Bordeaux University Hospital, Bordeaux, France.

Zitieren

APA

Abadie, Y., Visentin, J., Wojciechowski, E., Charrier, M., Déchanet-Merville, J., Garrigue, I., Blanco, P., Merville, P., Kaminski, H., & Couzi, L. (2025). Effector-Memory γδ T Lymphocytes Predict CMV Disease After the Withdrawal of Prophylaxis in Kidney Transplant Recipients. Transplant International. https://doi.org/10.3389/ti.2025.14339

Vancouver

Abadie Y, Visentin J, Wojciechowski E, Charrier M, Déchanet-Merville J, Garrigue I, et al. Effector-Memory γδ T Lymphocytes Predict CMV Disease After the Withdrawal of Prophylaxis in Kidney Transplant Recipients. Transplant International. 2025. doi:10.3389/ti.2025.14339

BibTeX
@article{Abadie2025,
  author = {Abadie, Yoann and Visentin, Jonathan and Wojciechowski, Elodie and Charrier, Manon and Déchanet-Merville, Julie and Garrigue, Isabelle and Blanco, Patrick and Merville, Pierre and Kaminski, Hannah and Couzi, Lionel},
  title = {Effector-Memory γδ T Lymphocytes Predict CMV Disease After the Withdrawal of Prophylaxis in Kidney Transplant Recipients},
  journal = {Transplant International},
  year = {2025},
  doi = {10.3389/ti.2025.14339}
}
Kostenlos starten →